La Poste will sell the 90% stake in Xange Private Equity it owns through its La Banque Postale division to Siparex, buying back a 20% share.

Swansea University is set to support research commercialisation and spinouts with individual investments of up to $77,500.

Technical University of Dresden has spun out a new company which identifies diseases through a high-speed camera.

MorphoSys, which owned a 20% stake following Lanthio's 2012 series A round, paid $22.5m for the remainder of the drug developer's shares.

CNC equipment maker Altec received $9.3m from Business Growth Fund and returnable transit packaging producer PPS $7.4m.

The media company held a 50.1% stake in the running and cycling app developer, which has been bought by Adidas, having invested an undisclosed sum in 2013.

Cambridge University licenses Wizard, an app for treating schizophrenia, to game developer Peak.